Balyasny Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-19,921
| Closed | -$1.17M | – | 2547 |
|
|
2023
Q4 | $1.17M | Sell |
19,921
-755,826
| -97% | -$44.4M | ﹤0.01% | 1159 |
|
|
2023
Q3 | $33.8M | Buy |
+775,747
| New | +$33.8M | 0.07% | 305 |
|
|
2023
Q2 | – | Sell |
-60,724
| Closed | -$2.26M | – | 2530 |
|
|
2023
Q1 | $2.26M | Buy |
60,724
+15,183
| +33% | +$565K | 0.01% | 1067 |
|
|
2022
Q4 | $2.06M | Buy |
+45,541
| New | +$2.06M | 0.01% | 1034 |
|
|
2021
Q1 | – | Sell |
-77,464
| Closed | -$17M | – | 1960 |
|
|
2020
Q4 | $17M | Buy |
+77,464
| New | +$17M | 0.09% | 270 |
|
|
2020
Q1 | – | Sell |
-4,645
| Closed | -$599K | – | 1472 |
|
|
2019
Q4 | $599K | Buy |
+4,645
| New | +$599K | ﹤0.01% | 861 |
|
|
2019
Q1 | – | Sell |
-75,166
| Closed | -$3.19M | – | 1589 |
|
|
2018
Q4 | $3.19M | Buy |
75,166
+24,434
| +48% | +$1.04M | 0.02% | 528 |
|
|
2018
Q3 | $2.39M | Buy |
+50,732
| New | +$2.39M | 0.01% | 736 |
|
|
2018
Q1 | – | Sell |
-12,300
| Closed | -$224K | – | 2098 |
|
|
2017
Q4 | $224K | Sell |
12,300
-9,300
| -43% | -$169K | ﹤0.01% | 1607 |
|
|
2017
Q3 | $253K | Buy |
+21,600
| New | +$253K | ﹤0.01% | 1402 |
|
|
2016
Q1 | – | Sell |
-8,020
| Closed | -$253K | – | 1364 |
|
|
2015
Q4 | $253K | Buy |
+8,020
| New | +$253K | ﹤0.01% | 885 |
|
|
2015
Q2 | – | Sell |
-52,342
| Closed | -$1.54M | – | 1134 |
|
|
2015
Q1 | $1.54M | Buy |
+52,342
| New | +$1.54M | 0.01% | 455 |
|